Match Document Document Title
DE102004061145A1 New glucopyranosyl-substituted benzene derivatives are sodium-dependent glucose cotransporter inhibitors, useful for treating e.g. metabolic disorders (type 1 and type 2 diabetes mellitus or metabolic acidosis)  
Glucopyranosyl-substituted benzene derivatives (I) and their tautomers, sterioisomers andsalts are new. Glucopyranosyl-substituted benzene derivatives of formula (I) and their tautomers,...
DE102004058449A1 tetrahydropyran  
New Compounds of the formula I, whereinT, E, R, R ', R' ', R1, R2 and R2 ' the meanings given in claim 1 have,useful as antidiabetics.
DE20023815U1 Azithromycin-containing compositions  
Pharmaceutical A composition comprising azithromycin in the form of a stable Monohydrate and at least one pharmaceutical carrier or Filler, wherein the azithromycin monohydrate is prepared by a...
DE102004058811A1 A process for the production of sugar alcohols  
It is a process for the preparation of polyalcohols, in particular Sugar alcohols from the group sorbite and mannitol and if necessary further polyols, proposed by a mono-, di-, oligo- or...
DE10145553B4 Nucleic acid for a cloning  
process for preparing a nucleic acid in a cloning vector or suitable for incorporation into a cloning vector, the method comprising the steps of: (A) providing a nucleic acid, at least one of...
DE102004056980A1 A method for site-specific synthesis of biopolymers on solid supports  
The Invention relates to methods for site-specific synthesis of biopolymers such as nucleic acids or peptides, and their respective derivatives on solid supports, wherein the local Discrimination...
DE102004034849B4 A process for preparing oat husks for xylan production  
According to the invention is a Oat husks for xylan production having the step, oat hulls by roughen a roll mill at its surface, wherein the coating layer partially destroyed the oat hulls , while...
DE19882655B4 A process for producing a probe for nucleic acid hybridization  
process for the manufacture of probes with or Oligodesoxyribonukleinsäuren Nucleic acid analogs a sequence detection part (SET) and a reporter group (RG), wherein the probes sufficiently...
DE19810349B4 Chitindeacetylasegen, vector containing this gene and transformants  
Polynucleotide molecule, a the Protein deacetylase for N-acetyl groups in N-acetylated Aminozuckerresten or a functional fragment it encodes, said polynucleotide molecule (A) is a polynucleotide...
DE19603629B4 A process for preparing alkyl glycoside  
process for the production of an alkyl glycoside by reaction of a saccharide and a monohydric alcohol or phenol, which process comprises comprising steps of: implementation of Reaction of the...
DE102004054603A1 New D-xylopyranosyl-substituted phenyl compounds are sodium-dependent glucose cotransporter inhibitors useful to prevent or treat e.g. diabetes mellitus, complications of diabetes, metabolic acidosis or ketosis  
D-Xylopyranosyl-substituted phenyl compounds (I) and tautomers and/or stereoisomers and salts are new. D-Xylopyranosyl-substituted phenyl compound of formula (I) and tautomers and/or stereoisomers...
DE19602464B4 Apparatus for multiple, simultaneous and parallel synthesis of chemical compounds and discrete follow aliquots  
device for multiple, simultaneous and parallel synthesis of chemical compounds with a holder (46) having a plurality of reaction vessels (12) an upper opening (22), said upper openings (22) the...
DE102004051804A1 Beta-L-N4-hydroxycytosine-deoxynucleosides and their use as pharmaceutical agents for the prophylaxis or therapy of viral diseases  
The Invention relates to β-L-N4-hydroxycytosine nucleosides and pharmaceutical compositions comprising them and the use of the β-L-N4-hydroxycytosine nucleosides and the pharmaceutical agent for...
DE102004050101A1 Recombined polypeptide antibody or antibody fragment binds the ED-B domain of Fibronectin  
Novel recombined polypeptide which is an antibody or an antibody fragment, which binds the ED-B domain of Fibronectin, and inhibits the interaction between the ED-B domain and its receptors....
DE10328813B4 Method for investigating cytosine methylation in DNA sequences by means triplexbildender oligomers  
process for the detection of cytosine methylations in DNA, characterized in that that the to be examined with a DNA molecule into contact triplexbildenden brings that distinguishes between...
DE4414863B4 A process for producing storable sulfosuccinates and Sulfosuccinamates  
process for the preparation of storage-stable sulfosuccinates and sulfosuccinamates by reaction of fatty alcohols or fatty amines or alkylene oxide adducts thereof with maleic anhydride and...
DE10231370B4 Thiophenglycosidderivate, medicaments containing these compounds and methods for making these medicines  
compounds of formula I, which mean R1, R2 Hydrogen, F, Cl, Br, I, OH, CF3, NO2, CN, COOH, CO (C1-C6) Alkyl, COO (C1-C6) Alkyl, CONH2, CON (C1-C6) -alkyl, CON [(C1-C6) Alkyl]2, (C1-C6) Alkyl,...
DE102004048390A1 New inhalation powders based on modified lactose mixtures as an adjuvant  
The Invention relates to a novel production method for displaying modified Lactose mixtures, these mixtures of lactose as such and composition medicaments for inhalation powder, consisting of one...
DE102004048389A1 Modifying surfaces of lactose as an excipient for use in powdered inhalants  
The Invention relates to a method for surface energy passivation of lactose, in the manufacture of inhalable powders as an excipient should be employed, as well as the use of such an optimized...
DE102004048388A1 D-pyranosyl substituted phenyls, medicaments containing these compounds, their use and processes for their preparation  
D-pyranosyl substituted Phenyls of general formula I, wherein the radicals R1 to R5, X, Z and R7a, R7b, R7c are as defined in claim 1, having an inhibitory effect on the sodium-dependent glucose...
DE102004047722A1 A method for isolating and separating carbohydrates from aqueous media  
The This invention relates to a method for isolating and separating carbohydrates, particularly monosaccharides, disaccharides and / or Oligosaccharides from aqueous Media, wherein the organic...
DE102004047269A1 New protein or peptide involved in biosynthesis of lysolipins, useful for preparing lysolipin antibiotics in transformed cells  
Isolated protein or peptide (I) comprising an amino acid sequence selected from (SEQ ID No.:1)-(SEQ ID No.:1 46), as given in the specification, is new. Independent claims are also included for:...
DE102004046116A1 Pullulanases from psychrophilic organisms  
The This invention relates to novel hydrolases, in particular pullulanases, from psychrophilic organisms and their use.
DE10347710B4 Recombinant vaccines and their use  
Fusion molecule, the Antigen, a transmembrane region and the cytoplasmic region a chain of an MHC molecule includes.
DE102004062597A1 Method to modify hyaluronate gel to produce a supramolecular gel, useful e.g. as medicine product to treat skin problems, comprises agitating aqueous hyaluronate solution for long time, exposing to UV radiation and distilling the solution  
A method for the modification of a hyaluronate gel to produce a supramolecular gel (I), which in its modified condition is able to penetrate the skin barrier and resumes it's original stable...
DE102004046583A1 New D-xylopyranosyl-phenyl-substituted cycle compounds useful for treating e.g. diabetes mellitus, complications of diabetes, metabolic acidosis or ketosis  
D-xylopyranosyl-phenyl-substituted cycle compounds, their tautomers, stereoisomers, mixtures and salts are new. D-xylopyranosyl-phenyl-substituted cycle compounds of formula (I), their tautomers,...
DE102004046012A1 New D-glucopyranosylphenyl-substituted cyclic compounds useful as sodium-dependent glucose cotransporter inhibitors for treating metabolic diseases, e.g. diabetes  
D-glucopyranosylphenyl-substituted cyclic compounds (I) are new. D-glucopyranosylphenyl-substituted cyclic compounds of formula (I) and their tautomers, stereoisomers and salts, other than...
DE102004036314A1 New D-glucopyranosylphenyl-substituted cyclic compounds useful as sodium-dependent glucose cotransporter inhibitors for treating metabolic diseases, e.g. diabetes  
D-glucopyranosylphenyl-substituted cyclic compounds (I) are new. D-glucopyranosylphenyl-substituted cyclic compounds of formula (I) and their tautomers, stereoisomers and salts, other than...
DE102004035337A1 Variants of the group 1 allergens from Poaceae with reduced allergenicity and received T cell reactivity  
The This invention relates to the preparation and use of Variants of the group 1 allergens of the Poaceae (grasses), which the by opposite known wild-type allergens reduced IgE reactivity and...
DE10222632B4 Microsatellite markers for genetic analysis and to distinguish it from roses  
oligonucleotides microsatellite markers of Rose genome characterized by the following sequences:
DE102004045332B3 Process and assembly to elute single and twin-strand nucleic acids from a sample substrate substance in the presence of a bivalent metal ion  
A process insulates and separates single and twin-strand nucleic acids from a sample substrate substance. The twin-stranded nucleic acids are eluted with a first elution solution and the...
DE10040380B4 MRI contrast agent for visualization of plaque, lymph nodes, infarcted and necrotic tissue or both necrosis and tumors, comprising perfluoroalkylated metal complex having specific micelle forming properties  
Use of perfluoroalkylated metal complexes (I), having a critical micelle formation concentration of less than 1 mM, a hydrodynamic micelle diameter of more than 1 nm and a proton relaxivity in...
DE102004040168A1 New glucopyranosyl-substituted benzene derivatives are sodium-dependent glucose cotransporter inhibitors, useful for treating e.g. metabolic disorders (type 1 and type 2 diabetes mellitus or metabolic acidosis)  
Glucopyranosyl-substituted benzene derivatives (I) and their tautomers, sterioisomers andsalts are new. Glucopyranosyl-substituted benzene derivatives of formula (I) and their tautomers,...
DE19911504B4 A process for the industrial oxidation of alcohols, aldehydes or polyhydroxy compounds  
process for the industrial oxidation of alcohols, aldehydes or polyhydroxy compounds in aqueous Phase, characterized in that the oxidation catalytic using a noble metal catalyst, the precious...
DE102004039096A1 New D-xylopyranosyl-phenyl-substituted cycle compounds useful for treating e.g. diabetes mellitus, complications of diabetes, metabolic acidosis or ketosis  
D-xylopyranosyl-phenyl-substituted cycle compounds, their tautomers, stereoisomers, mixtures and salts are new. D-xylopyranosyl-phenyl-substituted cycle compounds of formula (I), their tautomers,...
DE19628454B4 Rhamnolipid alginate complex microbiological process for its production, rhamnolipid alginate complex compositions and their uses  
Rhamnolipid alginate complex from blocks of structures obtainable by a microbiological Method for generating a fermentation rhamnolipid alginate complexes capable Bacteria of the genus...
DE102004034849A1 A process for preparing oat husks for xylan production  
According to the invention is a Oat husks for xylan production having the step oat hulls by roughen a roll mill in its surface, wherein the coating layer partially destroyed the oat hulls , while...
DE102004034474A1 Apparatus and method for efficient isolation of nucleic acids  
The This invention relates to an apparatus and a method for the efficient purification of nucleic acids and a kit for carrying out this Process.
DE102004032823A1 New D-xylopyranosyl-substituted phenyl compounds are sodium-dependent glucose cotransporter inhibitors useful to prevent or treat e.g. diabetes mellitus, complications of diabetes, metabolic acidosis or ketosis  
D-Xylopyranosyl-substituted phenyl compounds (I) and tautomers and/or stereoisomers and salts are new. D-Xylopyranosyl-substituted phenyl compound of formula (I) and tautomers and/or stereoisomers...
DE10258007B4 Aromatic Fluorglycosidderivate, medicaments containing these compounds and methods for making these medicines  
compounds of formula I, which mean R1, R2 OH, F or H; R3 OH or F, where one of R1, R2, R3 F must be; AO, NH, CH2, S or a Binding; R4, R5, R6 hydrogen, F, Cl, Br, I, OH, CF3, NO2, CN, COOH, CO...
DE102004031588A1 Using Äpfelsäureglucosiden as flavorings  
described the use of a Äpfelsäureglucosids [2- (glucosyl) -butan-1,4-dioic acid] or a physiologically salt of a akzeptalen Äpfelsäureglucosids as a flavoring, particularly as umami flavor and...
DE20122459U1 In situ hybridization of labeled oligonucleotide to antibody light chain sequence, useful for diagnosis of e.g. allergic, autoimmune and oncogenic diseases, in presence of formamide-free buffer  
In the in situhybridization of at least one labeled oligonucleotide (ON) to detect a sequence (I) that encodes the light chain of an immunoglobulin, the new feature is that contact between the ON...
DE10258008B4 Heterocyclic Fluorglycosidderivate, medicaments containing these compounds and methods for making these medicines  
compounds of formula I, which mean R1, R2 OH, F or H; R3 OH or F, where one of R1, R2, R3 F must be; AO, NH, CH2, S or a Binding; X is O, S or optionally substituted with R6 N, in the case X = O...
DE102004034690A1 Methylidene-D-xylopyranosyl and oxo-D-xylopyranosyl-substituted phenyls, medicaments containing these compounds, their use and processes for their preparation  
D-xylopyranosyl-substituted phenyls of the general formula I, wherein the radicals R1 to R5, X, Z and R7a, R7b, R7c are as defined in claim 1, having an inhibitory effect on the sodium-dependent...
DE102004034433A1 A process for the purification and isolation of nucleic acids using cationic detergents  
The This invention relates to a method for purification and isolation of nucleic acids using cationic detergents of the general formula (I):Y+R1R2R3R4X-.whereinY is nitrogen or phosphorus,R1, R2,...
DE10015797B4 Multiplex analysis of DNA mixtures by means of photolytically readable DNA chips  
process to mass spectroscopic analysis of nucleic acids by means of a spatially defined Oligonucleotide chip, or array, characterized in that a complex Mixture of sequences is investigated...
DE202005016250U1 Topiramate and pharmaceutical formulations thereof  
topiramate characterized in that it is present in highly pure form and at least 90% of the particles have a particle size of ≤ 250 microns.
DE10231659B4 Composition for binding nucleic acid to a solid phase  
composition for binding of nucleic acids in aqueous solution to a solid phase containing a guanidinium salt, a buffering agent and a detergent, characterized in that the pH value of the solution...
DE19961182B4 Galactomannan oligosaccharides and processes for their preparation and their use  
process for the production of mannose and galactose-containing oligosaccharides from galactomannans of guar gum, wherein an aqueous solution or suspension of guar gum prepared using a bacteria of...
DE102004031116A1 Method of finding relevant substances pain using pain-relevant proteins  
The Invention relates to a method for discovering pain-related Substances using the proteins KIAA0378, BAB31214 / Q9BU64, OPA1 / KIAA0567, CPG2 / KIAA1756, LETM1, PID12832121 / FLJ20420 and PGRL...